✦ LIBER ✦

NMP22 IS PREDICTIVE OF RECURRENCE IN HIGH RISK SUPERFICIAL BLADDER CANCER PATIENTS

✍ Scribed by Yau, Paul; Chin, Joseph L; Pautler, Stephen; Razvi, Hassan; Izawa, Jonathan I

Book ID: 121965682
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)61801-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GENE PROFILE EXPRESSION MAY PREDICT RECU

GENE PROFILE EXPRESSION MAY PREDICT RECURRENCE IN HIGH RISK SUPERFICIAL BLADDER CANCER PATIENTS

✍ Puppo, Paolo; Pfeffer, Ulrich; Mirisola, Valentina; Larghero, Patrizia; Andreatt 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 137 KB

Usefulness of urinary NMP22 to detect tu

Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection

✍ Naoto Miyanaga; Hideyuki Akaza; Sadamu Tsukamoto; Toru Shimazui; Mikinobu Ohtani 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 216 KB

Urinary NMP22® BladderChek® Test in the

Urinary NMP22® BladderChek® Test in the Diagnosis of Superficial Bladder Cancer

✍ P.M.J. Moonen; L.A.L.M. Kiemeney; J.A. Witjes 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 184 KB

NMP22 IS A SENSITIVE, COST-EFFECTIVE TES

NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER

✍ ZIPPE, CRAIG; PANDRANGI, LAKSHMI; AGARWAL, ASHOK 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 426 KB

RE: NMP22 IS A SENSITIVE, COST-EFFECTIVE

RE: NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER

✍ Zippe, C.; Pandrangi, L.; Agarwal, A. 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 169 KB

RE: NMP22 IS A SENSITIVE, COST-EFFECTIVE

RE: NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER

✍ Casella, R.; Lehmann, K.; Gasser, T.C. 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 287 KB